Document Mentions (4 shared documents)

EFTA00044963_email_034_sub_004 - EFTA00044963_905

2 mentions1 same-page

Page ?Same page

liability for respecting and following my expressed wishes and directions. JOAQUIN, Y. MLP Counseled by Rot,ortBeaudouin. ;TM W.3d!cal Office • MCC NY -9-2019 Date 7 /41 /4 5 Signature of Witness Date 446 Patient's Signa NYM-NEW YORK MCC Date EFTA00045860 BP-S358.060 MEDICAL TREATMENT R

10.4 58.7 25.0 11.1 4.1 0.8 0.3 4.4 1.9 0.8 0.3 0.1 0.02 6.9-10.5 0.0-5.0 1.9.6.7 1.3.3.7 0.3-1.1 0.0.0.5 0.0.0.1 0.00-0.50 fL K/uL K/uL K/uL K/uL K/uL 10^3/uL HEMOGLOBIN A1C Hemoglobin A1C 5.7 - 6.4 Increased Risk > 6.4 Diabetes H 6.3 <5.7 SEROLOGY RPR Non-Reactive

EFTA00047963_email_024_sub_002 - EFTA00047963_611

2 mentions1 same-page

Page ?Same page

nability for respecting and following my expressed wishes and directions. Counseled by -9-2019 Date Patient's Signa Date it'. di Office : j MCC NY 7 11/(5 Signature of Witness Date NYM-NEW YORK MCC EFTA00048523 BP-S358.060 MEDICAL TREATMENT REFUSAL CDFRM SEP 05 U.S. DEPARTMENT OF JUST

EFTA00073831_sub_002 - EFTA00073831_149

2 mentions1 same-page

Page ?Same page

ons and its employees from any and all liability for respecting and following my expressed wishes and directions. Counseled by kmi W.1d:cal Omcc MCC NY Signature of Witness -2019 Date Patient's Signal 7/1/(5 Date NYM-NEW YORK MCC n 14 )5 Date EFTA00073975 BP-S358 06C MEDICAL TREATMENT REFU

11.1 Eosinophils % 4.1 Basophils % 0.8 Immature Granulocytes % 0.3 0.0-5.0 % Neutrophils # 4.4 1.9-6.7 K/uL Lymphocytes # 1.9 1.3-3.7 K/uL Monocytes # 0.8 0.3-1.1 K/uL Eosinophils # 0.3 0.0-0.5 K/uL Basophils # 0.1 Page 140 of 148 0.0-0.1 KJuL Immature Granulocytes # 0.02 0.